|
Market Closed -
Nasdaq
00:00:00 19/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.100 USD | +1.94% |
|
-8.50% | -32.04% |
| 10-06 | HeartSciences Inc. Receives FDA 510(k) Clearance for its MyoVista wavECG Device | CI |
| 10-06 | Top Premarket Decliners | MT |
| Market Cap | 9.89M 9.02M 8.34M 7.52M 14.17M 924M 14.73M 101M 39.81M 499M 37.1M 36.32M 1.57B | P/E 2027 * |
-0.72x | P/E 2028 * | -1.02x |
|---|---|---|---|---|---|
| Enterprise Value | 9.89M 9.02M 8.34M 7.52M 14.17M 924M 14.73M 101M 39.81M 499M 37.1M 36.32M 1.57B | EV / Sales 2027 * |
578x | EV / Sales 2028 * | 3.14x |
| Free-Float |
80.02% | Yield 2027 * |
-
| Yield 2028 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HSCS | Delayed | |
| HSCS | Real-time |
| 1 day | +1.94% | ||
| 1 week | -8.50% | ||
| Current month | -36.56% | ||
| 1 month | -31.60% | ||
| 3 months | -1.41% | ||
| 6 months | +12.90% | ||
| Current year | -32.04% |
| 1 week | 2 | 2.34 | |
| 1 month | 2 | 3.68 | |
| Current year | 1.63 | 5.25 | |
| 1 year | 1.63 | 5.25 | |
| 3 years | 1.63 | 29 | |
| 5 years | 1.63 | 600 | |
| 10 years | 1.63 | 600 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Simpson
CEO | Chief Executive Officer | 57 | 01/03/2022 |
Danielle Watson
DFI | Director of Finance/CFO | 44 | 01/04/2022 |
Aaron Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Simpson
CHM | Chairman | 57 | 01/06/2013 |
Brian Szymczak
BRD | Director/Board Member | 54 | 01/01/2014 |
Bruce Bent
BRD | Director/Board Member | 70 | 01/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/7/26 A | Free | Chief Financial Officer | 25,000 | 0.7598% | ||
| 1/12/26 A | Free | Director | 15,000 | 0.4720% | ||
| 1/12/26 A | Free | Director | 15,000 | 0.4720% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.94% | -8.50% | -30.69% | -88.65% | 9.89M | ||
| +0.87% | -3.48% | +20.26% | +47.70% | 254B | ||
| +1.24% | -2.86% | +1.36% | +8.32% | 159B | ||
| -2.23% | -6.36% | -23.01% | +35.21% | 149B | ||
| +1.42% | -3.30% | -56.02% | -19.87% | 62.37B | ||
| -0.19% | -0.55% | +25.21% | +56.62% | 60.62B | ||
| +1.25% | +2.10% | +4.93% | -12.39% | 53.05B | ||
| +2.97% | +0.21% | +23.28% | +55.58% | 48.55B | ||
| -3.89% | -9.05% | +1.27% | +55.11% | 46.7B | ||
| +3.63% | -1.02% | +23.76% | +78.63% | 44.21B | ||
| Average | +0.80% | -4.45% | -0.96% | +21.62% | 88B | |
| Weighted average by Cap. | +0.56% | -3.00% | +2.82% | +33.02% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 17.1K 15.6K 14.42K 13.01K 24.51K 1.6M 25.47K 174K 68.84K 862K 64.15K 62.81K 2.72M | 3.15M 2.87M 2.66M 2.4M 4.51M 294M 4.69M 32.08M 12.68M 159M 11.82M 11.57M 502M |
| Net income | -12.32M -11.24M -10.39M -9.37M -17.66M -1.15B -18.35M -125M -49.59M -621M -46.22M -45.25M -1.96B | -10.6M -9.66M -8.93M -8.06M -15.18M -990M -15.78M -108M -42.65M -534M -39.75M -38.92M -1.69B |
| Net Debt | - | - |
Employees
14
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/11/26 | $2.100 | +1.94% | 15,659 |
| 17/11/26 | $2.060 | -0.96% | 17,544 |
| 16/11/26 | $2.080 | -2.12% | 29,846 |
| 13/11/26 | $2.125 | -5.97% | 35,705 |
| 12/11/26 | $2.260 | -1.53% | 86,306 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.060USD
Average target price
12.00USD
Spread / Average Target
+482.52%
- Stock Market
- Stocks
- HSCS Stock
Select your edition
All financial news and data tailored to specific country editions
















